Clinical trial · Observational
Value of Physical Capacity Tests in Lung Cancer
Prospective Observational Cohort Study of the Value of the Six Minute Walk Test and Handgrip Strength in Lung Cancer Patients Undergoing Chemotherapy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study examines the physical capacity of lung cancer patients assessed with the six minute walk test and handgrip strength. Demographic and selfreported exercise behavior is registered to explore correlations to functional and physical capacity. Assessments are made before first chemotherapy cycle and after fourth chemotherapy cycle, an expected average of 12 weeks between first and second assessment.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non Small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
| Small Cell Lung Cancer | Lung Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- lung cancer patients
- description
- Non Small Cell Lung Cancer, Small Cell Lung Cancer
Primary outcomes (1)
- measure
- Mortality - Survival time
- timeFrame
- time from first chemotherapy treatment to death, assessed after 30 months
- description
- Prognostic value of the six minute walk and handgrip strength on mortality
Secondary outcomes (3)
- measure
- Hand grip strength
- timeFrame
- before first chemotherapy and after fourth cycle of chemotherapy, an expected average of 12 weeks between first and second assessment.
- measure
- Self reported exercise behavior
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Non small cell lung cancer stage I-IV * Small cell lung cancer * Patients \>18 years * WHO performance status 0-2 * undergoing chemotherapy Exclusion Criteria: * unstable angina during the previous month * myocardial infarction diagnosed within the last month * not approval for physical activity by primary oncologist * inability to provide informed consent.
References
Publications (0)
Data not yet available